跳至主要内容
临床试验/DRKS00006102
DRKS00006102已完成3 期

Pharmacodynamic comparison of thienopyridine loading strategies in patients undergoing elective coronary stenting - ExcelsiorLOAD

niversitäts-Herzzentrum Freiburg - Bad Krozingen0 个研究点目标入组 300 人开始时间: 2014年5月21日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Stable patients with obstructive coronary heart disease and planned coronary stent implantation.
  • Pretreatment with aspirin (100mg daily or loading dose of 400mg before coronary angiography).
  • Age >= 18 years.
  • Written informed consent.

排除标准

  • Acute myocardial infarction
  • Treatment with ticagrelor, prasugrel, fibrinolysis, or GP IIb/IIIa inhibitor within 7 days before enrollment.
  • Contraindication for treatment with aspirin, clopidogrel, or prasugrel (in particular: active bleeding, history of stroke or TIA).
  • Current oral anticoagulation.
  • Severe thrombocytopenia (< 50.000/µl).
  • Known severe disorder of the coagulation system.
  • Participation in another drug trial.
  • Pregnancy or lactation.
  • Persons with a state of dependence with sponsor or investigator.
  • Commitment to an institution.
  • Dementia or other psychatric disorder (e.g., drug abuse) that prevents sufficient informed consent.

研究者

发起方
niversitäts-Herzzentrum Freiburg - Bad Krozingen

相似试验

已完成
不适用
Comparative evaluation of thienopyridines on platelet aggregation in patients with ischemic heart disease in multi-centers in Okinawacoronary heart disease
JPRN-UMIN000023489Graduate School of Medicine, University of Ryukyus Department of Cardiovascular Medicine, Nephrology and Neurology160
已完成
不适用
The effect of changing thienopyridine drugs on platelet aggregation for patients with acute and elective stent placement in coronary arteryIschemic heart diseases with PCI
JPRN-UMIN000015122Kurume University Hospital150
已完成
不适用
Interaction between human immunodeficiency virus (HIV) drugs (non-nucleoside reverse transcriptase inhibitors [NNRTIs]) and anti-platelet agents
ISRCTN68035289Royal Liverpool University Hospital and the University of Liverpool?s Biomedical Research Centre (UK)37
进行中(未招募)
1 期
EFFECT OF THIENOPYRIDINE DERIVATIVE (CLOPIDOGREL) ON THE DISPOSITION OF EFAVIRENZ AND NEVIRAPINE IN HIV POSITIVE PATIENTS - Interaction between HIV drugs (NNRTIs) and Anti-platelet agentTo determine whether anti-platelet agent clopidigrel influences the disposition of NNRTIs (efavirenz and nevirapine)
EUCTR2008-006371-67-GBRoyal Liverpool and Broadgreen University Hospital37
进行中(未招募)
不适用
ETAMI-Study is a clinical trial that tests whether treatment with a new drug (thienopyridine) is able to improve performance and outcome of PCI (i.e. balloon inflation to re-open an occluded vessel in the heart) in patients that suffered myocardial infarction (i.e. acute disease in which one ore more of the blood vessels supplying the heart itself are occluded).
EUCTR2010-019461-29-DEStiftung Institut für Herzinfarktforschung70